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Abstract
Background: Patients belonging to marginalised (medically under-served) groups experience problems with
medicines (i.e. non-adherence, side effects) and poorer health outcomes largely due to inequitable access to
healthcare (arising from poor governance, cultural exclusion etc.). In order to promote service equity and outcomes
for patients, the focus of this paper is to explore the implementation and impact of a new co-produced digital
educational intervention on one National Health Service (NHS) funded community pharmacy medicines
management service.
Methods: Semi-structured interviews with a total of 32 participants. This included a purposive sample of 22
community pharmacy professionals, (16 pharmacists and 6 pharmacy support staff) all who offered the medicine
management service. In order to obtain a fuller picture of the barriers to learning, five professionals who were
unable to complete the learning were also included. Ten patients (from a marginalised group) who had received
the service (as a result of the digital educational intervention) were also interviewed. Drawing on an interpretative
analysis, Normalisation Process Theory (NPT) was used as a theoretical framework.
Results: Three themes are explored. The first is how the digital learning intervention was implemented and
applied. Despite being well received, pharmacists found it challenging completing and cascading the learning due
to organisational constraints (e.g. lack of time, workload). Using the four NPT constructs (coherence, cognitive
participation, collective action and reflexive monitoring) the second theme exposes the impact of the learning and
the organisational process of ‘normalisation’. Professional reflective accounts revealed instances where inequitable
access to health services were evident. Those completing the intervention felt more aware, capable and better
equipped to engage with the needs of patients who were from a marginalised group. Operationally there was
minimal structural change in service delivery constraining translation of learning to practice. The impact on patients,
explored in our final theme, revealed that they experience significant disadvantage and problems with their
medicines. The medication review was welcomed and the discussion with the pharmacist was helpful in addressing
their medicine-related concerns.
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Conclusions: The co-produced digital educational intervention increases pharmacy professionals’ awareness and
motivation to engage with marginalised groups. However structural barriers often hindered translation into practice.
Patients reported significant health and medicine challenges that were going unnoticed. They welcomed the
additional support the medication review offered. Policy makers and employers should better enable and facilitate
ways for pharmacy professionals to better engage with marginalised groups. The impact of the educational
intervention on patients’ health and medicines management could be substantial if supported and promoted
effectively.
Keywords: Community pharmacy, Co-production, Digital learning, Medically under-served groups, Medicines use
reviews (MURs), Normalisation process theory (NPT)
Background
The right to physical and mental health without discrim-
ination is recognised as a universal human right [1].
However, even within affluent societies, research indi-
cates that vulnerable people from marginalised or ‘med-
ically under-served groups’ (Table 1) experience
significant inequitable access to health and find navigat-
ing health and screening services more challenging when
compared to the general population [2–4]. Patients who
identify as belonging to these groups encounter poorer
patient-professional communication [5] and sometimes
racism or cultural bias [6–8]. They also hold strong be-
liefs that they cannot be helped [9], face discrimination
or disempowerment because of their circumstance [10],
and are disenfranchised from mainstream primary health
care [11]. Inequitable access to routine or preventative
care risks higher rates of emergency admissions [12, 13]
and increases pressure on acute services [14]. New strat-
egies or care pathways to reduce inequitable healthcare
access are urgently needed and are a priority for the
NHS [15].
Internationally, there is growing global interest in
reforming primary care systems that seek to improve
health equity [16]. Health educators have sought to re-
frame social determinants of health so they are seen less
as “facts to be known” and more as “conditions to be
challenged and changed” [17]. Included in this move-
ment is health professional cultural competence training
which has unfortunately shown limited impact beyond
increasing knowledge and improving attitudes [18]. As
such, there are now moves to teach the subject in a
more nuanced way, moving away from pedagogic ap-
proaches of cultural competency towards a dynamic
model that utilises frameworks of structural competency
and critical consciousness [19, 20]. One limitation how-
ever, is that existing inequity reduction frameworks and
models lack important guidance to organisations for the
practical implementation of translating ambitions and
macro policies into guided day-to-day action for front-
line health professionals [21].
With this in mind, we draw on Normalisation Process
Theory (NPT) to investigate the impact of a novel digital
educational intervention (e-learning resource) to improve
access in one NHS-funded community pharmacy service
known as ‘Medicines Use Reviews’ (MURs). Co-
production is an equal partnership (through the sharing of
power) between service providers and service users (or
other members of the community), where both parties
make substantial resource contributions [22]. This con-
cept has been shown to produce positive patient outcomes
[23]. Moreover, on-line educational tools have also been
shown to support professional learning and bring practice
improvements [24, 25]. This study explores the implemen-
tation and impact of a novel co-produced digital educa-
tional intervention to promote service equity and
outcomes for patients. Through this, we extend the debate
on how difficult new patterns of behaviour are normalised
in existing cultures of practices, processes and policies, as
well as investigate the regulative and organisational ele-
ments that contribute to resistance [26].
Table 1 Examples of communities or groups that could be
medically under-served
• People with disability i.e., people with physical disability (e.g., a
person in a wheelchair); people with visual impairment (Partially
sighted/blind); people with hearing impairments (deaf) people with
learning impairment (e.g., Downs syndrome, autism etc.)
• People from Black, Asian and Minority Ethnic (BAME) communities
• People who are homebound, from rural communities
• People from Gypsy, Roma and Traveller (GRT) communities
• People who are homeless or have no fixed address
• People who are refugees or are seeking asylum
• People from the lesbian, gay, bisexual and transgender, queer
(LGBTQ) communities
• People with mental health illness and stigmatised medical
conditions (e.g., acquired immune deficiency syndrome (AIDS),
epilepsy)
• Older people, particularly with multiple morbidities and medicines
• Young people (specifically men aged 18–25)
• People from a low socio-economic status, long-term unemployed,
low levels of health literacy
• People with speech disorders (e.g., stutter) or language disorders
e.g., from brain injury (stroke, dementia)
• People experiencing substance misuse (e.g. alcohol, illicit drug
dependency)
• People who have experienced domestic/physical abuse
• People who are sex workers
• People in prison or those who are known to have been in prison
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Medicine Use Reviews (MURs)
In light of the growing evidence suggesting patients ex-
perience significant problems taking medicines [27],
concerns over medicine wastage, and adverse effects due
to inappropriate polypharmacy [28], the United King-
dom (UK) Department of Health commissioned a na-
tional ‘Medicine Use Review’ (MUR) service in 2005.
This was to be delivered from pharmacies as an optional
‘advanced service’ to support patient understanding and
adherence to therapy [29]. The service is currently of-
fered in approximately 90% of pharmacies and is free to
patients. It is organised as an annual, one-to-one
patient-pharmacist consultation aiming to resolve medi-
cine adherence-related problems, address medicine-
related concerns and to reduce avoidable waste. At the
time, this move was based on emerging international
evidence that pharmacist-led medication review models
were feasible [30], and effective at improving medication
adherence and health outcomes [31, 32]. There was also
a willingness of the pharmacy profession to extend the
pharmacists’ role beyond dispensing and information-
giving, towards health promotion, prescribing and sup-
porting medicine-use [33].
The implementation of MURs into pharmacist rou-
tines and practices however, has not been straight-
forward. Questions have been raised over the variability
in service delivery [34, 35]. With little formal monitoring
or supervision, concerns have been expressed over the
value to patients [36] and whether MURs are being tar-
geted to “local needs and patient priorities” [37] leading
to measures to phase out the service. One cause of these
problems is the way pharmacies are remunerated for
MURs. The NHS offers contractors a fee of £28 for each
review performed, with the total number each pharmacy
can claim subject to a cap of 400 annually. This cap,
however, appears to have created a target-driven organ-
isation culture [34, 35] in which contractors strive to
claim as many reviews as allowed. There have been no
requirements or incentives for pharmacists to recruit
vulnerable patients from marginalised or medically
under-served groups. With vulnerable patients from
these groups likely to be in more need of support, there
is scope for an intervention that raises awareness and
engagement with people who may benefit the most.
With over 3 million MURs conducted annually, we
hypothesised that a co-produced digital educational
intervention could be well placed to improve the
provision of MURs to marginalised, medically under-
served groups.
Co-produced digital learning intervention
Novel, co-operative and inclusive initiatives that engage
with vulnerable populations have been suggested as a
way to improve healthcare access [9, 38]. This study
used the co-production philosophy which acknowledges
that stakeholders including services users and members
of the public are best placed to advise on how services
can be made more accessible to them, while also appre-
ciating the input of front-line healthcare staff responsible
for service delivery [22, 23]. In order to co-develop the
educational intervention, mixed patient-professional
workshops and qualitative one-to-one interviews with
pharmacists and patients from under-served communi-
ties were undertaken. The final intervention comprised
of three web-based digital learning resources:
1. Discovering and understanding under-served
communities,
2. Exploring the medicine experiences and needs of
patients who are under-served,
3. Effectively interacting and engaging patients who
are under-served.
In order to engage the learner in interactive learning,
each resource consists of a mixture of multimedia ele-
ments (i.e., audio, images, activities and illustrative vid-
eos) and represents approximately 15–20min of
learning activity. The first resource was co-developed
following the revelation that there is low levels of know-
ledge among pharmacy professionals of who is ‘medically
under-served’. The second sought to cultivate empathy
and to better understand the lived experiences of such
patients. The last resource, provided the learner with
steps on how they could empower patients to take up
the offer of an MUR. The resource is freely accessible
online and can be accessed through our dedicated web-
site found at:
https://www.nottingham.ac.uk/helmopen/rlos/phar-
macy/practice/under-served/[39].
Further details of the development of the digital edu-
cational intervention have been reported in the study
protocol [40] and elsewhere [41].
Theoretical framework
Normalisation process theory (NPT)
Normalization process theory (NPT) is a widely used
theoretical framework and was used in this study to
identify, characterise and explain key mechanisms that
facilitate or inhibit the embedding or normalisation of
the complex intervention; it has been used widely to ex-
plore the implementation of new technologies or new
processes in health care settings [42]. The theory pro-
poses that “material practices become routinely embed-
ded in social contexts as the result of people working,
individually and collectively, to implement them” [43].
NPT offer a generalisable framework that can be applied
across settings with opportunities for incremental know-
ledge gain over time [44]. One of the key strengths of
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the NPT is that it highlights potential social, cultural
and organisational barriers to implementation, compared
with more individualistic approaches such as the theory
of planned behaviour [45]. A qualitative systematic re-
view by McEvoy et al. [46] of studies applying the NPT
framework to research implementation processes sug-
gested healthcare researchers had positive responses and
outcomes to the theory. In the pharmacy context NPT
has been useful to examine experiences of delivering
community pharmacy service to support adherence and
self-management in chronic heart failure [47].
May and Finch [43] operationalise 4 constructs that
form the framework:
1. Coherence (sense-making work)
e.g. shared understanding
2. Cognitive participation (relational work)
e.g. defining procedures
3. Collective action (operational work)
e.g. allocation of work
4. Reflexive monitoring (appraisal work)
e.g. determining effectiveness
Method
This qualitative study is part of a larger appraisal of the
co-produced digital educational intervention carried out
between April 2016 and March 2019 [40]. The appraisal
included a before / after survey study which was under-
taken in community pharmacies located in Nottingham-
shire, England. The embedded qualitative study aimed to
develop an in-depth understanding of professionals’ situ-
ated practices, cultural context and organisational faci-
litators and constraints within which the digital
educational intervention was implemented. All pharma-
cies in the Nottinghamshire area (n = 237) were
approached. Pharmacy staff who were actively involved
in the MUR service were invited to take part in the sur-
vey study. ‘Active involvement’ was defined as being in-
volved with the process of identifying, inviting or
undertaking MURs on a day-to-day basis. Survey re-
sponses were received from 122 pharmacies (involving
149 staff). At 3 months 62 participants had reported
accessing and completing the e-learning.
This study draws on a total of 32 interviews including
22 pharmacy professionals (16 pharmacists and 6 dis-
pensing staff) from the sample of pharmacy staff who
agreed to participate in the survey study. Pharmacy pro-
fessionals were purposefully selected reflecting variations
in pharmacy ownership and employment role. In order
to obtain a fuller picture of the barriers to learning, five
professionals were selected who had been offered but
unable to complete the digital educational intervention.
Ten patients were interviewed (who were identified as
belonging to one or more medically under-served
group(s)). Patients were recruited through 2 pharmacies
by pharmacists who had completed the learning inter-
vention. Once they had received their MUR from the
pharmacist, the patient was then invited to the study.
Patients and the recruiting pharmacy were offered a £25
High Street gift voucher as an inconvenience allowance.
To avoid gift vouchers being used as incentives to take
part in in an MUR, pharmacists were instructed to only
invite patients to the study following their acceptance to
have an MUR.
Qualitative, one-to-one, face-to-face semi-structured
interviews were undertaken by AL. Patient / profes-
sional interviews lasted approximately 30–45 min and
with the participants’ consent, were audio-recorded.
Using NPT as a theoretical framework, we explored
the impact of the e-learning on professional aware-
ness, attitudes and behaviours engaging with and in-
viting people who were medically under-served.
Professional motivation, barriers and facilitators to en-
gage with the learning were also explored (see Table 2
in Appendix for topic guide). Patient interviews ex-
plored their health and illness, medicine-taking habits
and experiences and personal value of the MUR.
Their feelings about being approached for an MUR
were also explored as well as thoughts on how
healthcare professionals could better engage with, and
improve services to, medically under-served groups
(see Table 3 in Appendix for topic guide). Audio-
recorded interviews were transcribed verbatim. Data
were then imported into the qualitative analysis pack-
age NVivo [48] for coding using an interpretative
analytical approach. The coding framework was deve-
loped through emerging themes as well as around the
4 NPT constructs (coherence, cognitive participation,
collective action and reflexive monitoring).
Results
Implementation of the digital educational intervention
Our first theme considers how the resource was dis-
seminated and the training undertaken by pharmacy
professionals. Pharmacists were provided with an on-
line link to the learning and were responsible for cas-
cading this to relevant team members who were
actively involved with the MUR service. The resource
was described as concise, informative and relevant,
accommodating a range of different learning styles.
Despite its value, where there were short staffing
issues, they were hesitant to share the learning with
other staff over fears they would be burdening them
with extra work. This hindered the translation of the
learning into practice. Some professionals reported
feeling guilty for being seen to prioritise learning over
more pressing work; others reported completing the
resource at home, in their own time:
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It’s extraordinarily difficult to find the time at work.
There’s pressure to do 101 other things. I’m a travel
health pharmacist, I do meningitis vaccines, I do flu
vaccines, there’s a great pull on my time at work to do
the actual training. (Pharmacist_Male_51yrs_Chain
pharmacy).
We get a lot of e-learning and training here but
myself I feel like I am always rushed to go through
it as quickly as possible. … I feel I don’t want
anyone to think I’m slacking, I feel I should be back
on that counter. (Dispenser_Female_39yrs_Chain
pharmacy).
Table 2 Pharmacy staff topic guide
Background
• Tell me a little about yourself and your work?
• Tell me about your involvement in MURs (before the training) i.e.
how do you identify / select patients for an MUR?
• Are there any patients / groups you avoid?
• What do you intend to achieve from undertaking the service?
• Before the training what was your understanding of an under-served /
or ‘hard-to-reach' group?
Evaluation of the use and implementation of the digital learning using the
4 NPT constructs
Coherence
• Explore professionals’ description of the learning, meaning and
sense making
• Explore views of the purpose, benefits and value of the learning
• Explore how the learning will fit with the overall goals and activity
of the organisation
Cognitive Participation
• Explore professional opinions of whether the intervention is a good
idea
• Explore commitment and engagement with the learning
• Explore professionals’ preparedness to invest time and energy
Collective Action
• Explore how the learning was cascaded to the pharmacy team
• Explore the barriers and facilitators to effective translation into
practice & compatibility with pharmacy standard operating
procedures
• Explore the impact on resources, responsibility between staff and
other health professionals (e.g. GPs?)
Reflexive Monitoring
• Appraisal of the learning: has your knowledge of under-served com-
munities changed as a result of using the e-learning, do you have
any success stories?
• Explore the effects of the learning on practice i.e. has this changed
the way you undertake MURs as a result of the learning?
• Feedback: In what ways could the e-learning be improved /
adapted?
Any final comments? / thank the pharmacy professional.
Table 3 Patient topic guide
Background & circumstance
• Tell me a little about your background? Prompt: work and lifestyle
etc.
• Explore health status, medical conditions and current concerns
about health
Use of health services & medicine use
• Explore experiences of patients health care services
• Do you have any concerns or problems with the medicines currently
prescribed?
• Explore adherence i.e. are medicine taken as prescribed or have
these been changed?
• Do you ever miss doses of your medicine, if so when / why?
• Explore understanding of what medicines are for, concerns about
side effects, perceptions of effectiveness, reluctance to take etc
Relationship with pharmacy/pharmacist
• How often do you make use of your local pharmacy and what are
the reasons you use this?
• What has your experience with pharmacies & their staff been
(friendly, unfriendly, informative, discriminative etc.)?
• Have you ever been offered a pharmacy consultation when you visit
pharmacies? And what was your experience?
• What sort of support are you aware of being available from your
pharmacist? Can you recall any specific advice given by the
pharmacist?
• Have you ever asked a pharmacist for advice about your medicines
(details)? Do you think the pharmacist is someone that you could
approach for advice about your medicines? What prevents you from
asking at the pharmacy?
• If you have problems with your medication what if anything do you
intend to do about it? What would you like to do?
• How would you feel about being approached about using one or
more of these additional services?
Specific questions relating to their marginalised or under-served status
• Explore self-identification / belonging to a medically under-served
group
• Explore communication / cultural challenges (people who have
English as second language or from BAME community)
• Can you describe the difficulties that your disability has in accessing
or being offered community pharmacy services? (People with
disability)
• How do you think medicines services like the MUR can be better
tailored to others in the same circumstances as you?
Questions about their experience of the MUR
• Explore awareness of the MUR and expectation of the service?
• What did you think about the environment i.e. the size of the
counselling room?
• Can you describe how you felt during the consultation? (Prompt –
friendly, comfortable, nervous?)
• Explore patient’s perceived purpose of the MUR: What do you think
the purpose of this service was?
• What did you find most helpful & what did you find least helpful?
• In what ways, if any, has the MUR helped you with your medicines?
Have you changed the way you take your medicine according to
this advice?
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In a couple of cases, pharmacists were unable to
engage or motivate their teams. In these cases under-
taking the learning or sharing the resource was not
assumed to be high on their list of priorities:
Nobody else was interested in doing it I believe … I
suspect it was a time element for them …
(Pharmacist_Female_32yrs_Chain pharmacy).
I don’t know why we didn’t do it. It’s not something
that was high on the list of things for them to do I
guess … People who are old and been in the career for
decades, change is hard.
(Pharmacist_Male_46yrs_Independent pharmacy).
Impact of the learning: the process normalisation
Using the four NPT constructs, our second theme
explores the process of normalisation and impact of the
intervention on professional practice.
Coherence
The coherence construct primarily focuses on the initial
process of implementation and seeks to understand ac-
tor’s shared, or communal understanding of ideas, beliefs
and meaning of any new intervention. For participants
who had completed the learning, their awareness of
medically under-served groups had improved. The learn-
ing opened their minds and allowed them to develop
greater empathy with disadvantaged patients and their
circumstances:
So obviously these are real people giving their
experiences of MURs and their struggles, it sort of puts
you in their shoes, so you can understand where they
are coming from. You can identify exactly how they
feel and how they are being under-served.
(Pharmacist_Male_44yrs_Independent pharmacy).
As well as providing pharmacists opportunities for
reflection, the resource also allowed scope for deeper
consideration, introspection and for them to challenge
personal unconscious biases:
I don’t think anyone would maliciously try and go out
and say “You know what, I’m going to avoid that
definitely”, but I think you kind of look at it and
subconsciously avoid it. I think now it’s probably
opened my eyes that these are the kind of people who
are more in need of this service. They are the people I
should actively try and target.
(Pharmacist_Male_29yrs_Independent pharmacy).
I didn’t even realise that I had a bias even … so the e-
learning for me was brilliant … it challenged my as-
sumptions, my biases, my awareness of cultures, and
not a one size fits all kind of umbrella. (Pharmacist_-
Male_35yrs_Chain pharmacy).
In a minority of cases, pharmacists were less empath-
etic in light of excessive work pressures and government
cuts to their funding budgets. In these cases, given the
infrequency with which these groups presented, it was
easier for them to simply turn a ‘blind eye’:
I don’t have the time to constantly search out
vulnerable groups. Maybe that’s what we should be
doing, but in the current climate, that’s an impossible
thing to achieve. So, I’m going to go for the things
that are contractually required of me to do because
I’ve got enough on my plate already.
(Pharmacist_Male_43yrs_Independent pharmacy).
Cognitive participation
Cognitive participation, refers to both the real and sym-
bolic engagements and enrolments that must be made to
make collective action possible [43]. In practice, this is the
work, time and effort invested to integrate the new prac-
tice (effectively to buy into and support the new practice).
The translation of the learning to make the MUR service
more equitable was difficult; this was largely due to how
the work of the MUR was organised. Most reported
patient recruitment, even for those considered not to be
marginalised, to be challenging. It was suggested that this
was due to a general problem of patients not seeing the
value of an MUR, or even understanding what was in-
volved. With little patient-driven demand, organisational
and personal strategies were deployed to facilitate the
recruitment process. However, it became clear these
micro-level decisions inadvertently disadvantaged people
that were medically under-served. For example, stickers
labelled ‘MUR’ were routinely attached to assembled
prescriptions allowing staff to quickly identify eligible
patients. However, patient invitations were circumvented
where staff perceived it difficult to explain the service (i.e.
where patient had English as a second language) or where
patients were more challenging to recruit:
Table 3 Patient topic guide (Continued)
• Are there any outstanding problems with your new medicine or any
other medicine that you would like to have discussed with the
pharmacist during the consultation?
• Do you think the MUR was necessary for you?
• Would you recommend this service to others?
• Would you like to see any improvement in the way MURs are
carried out?
• Any final comments / thank the patient.
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Foreign people because there’s a bit of a language
barrier, so it’s hard to explain it to them. And elderly,
I guess, because they don’t really like to wait around,
they are agitated … You can tell people who are a bit
easier to approach than people who aren’t.
(Dispenser_Female_36yrs_Independent pharmacy).
Another example where certain patient groups were
side-lined, was when pharmacists experienced heavy dis-
pensing workloads. During these times, patients with
fewer medicines for whom the MUR could be performed
quickly and conveniently were preferred. They appre-
ciated that patients who were ‘cherry-picked’ in this way
may not receive as much benefit as for someone more
vulnerable:
Because of the time constraints most community
pharmacists will take the easier option … It’ll be
somebody who’ll be compos mentis, not deaf and not
challenging, just to fulfil the numbers. Are they
realistically the people who need the time and advice?
(Pharmacist_Male_52yrs_Chain pharmacy).
The main diver for offering the service was predomi-
nantly business-related. The fee for MURs were report-
edly used as a means to offset or recoup ongoing
government cuts to pharmacy budgets. Organisational
pressure from management to recruit a targeted number
of MURs was consequently evident. Role strain emerged
where offering a professional service conflicted with
notions of a target-driven commercial activity:
You find yourself under some tension because it’s
about the pressure to find one [MUR] and not the
pressure to support the patient.
(Pharmacist_Male_43yrs_Locum).
It is difficult sometimes to pick apart the need to hit
the targets rather than whether or not it’s the most
appropriate patient to do an MUR on.
(Dispenser_Female_30yrs_Chain pharmacy).
Collective action
Collective action is the work that people do to enact or
operationalise the new practice. This can be categorized
into immediate (e.g. having the right skillset to perform the
task) and organising factors (levels of support by the organ-
isation). Regarding the skills to engage and recruit patients,
practical issues around identifying and approaching people
who were marginalised was still seen as a barrier. This
applied, for example, where patients were unable to, or did
not regularly attend the pharmacy. Identifying patients who
were homeless was also perceived as difficult:
The problem with this pharmacy is 70–80% of our
business is delivery, sometimes we might not see the
person for 6, 7 or 8 months.
(Pharmacist_Male_40yrs_Independent pharmacy).
It’s very difficult to see if somebody’s homeless … In my
six years I’ve never seen a prescription where it says
“no fixed abode”, so are you telling me that in six
years having served thousands of patients, if not a
million patients, I’ve never served a homeless person?
(Pharmacist_Male_29yrs_Independent pharmacy).
Following the learning, there were few, if any, reported
changes to the pharmacy’s operating procedures. While
recognising that patients who were medically under-
served could benefit to a greater extent compared to
those not belonging to these groups, pharmacists still
weighed up this potential value against whether they
could afford the perceived extra time these MURs may
take:
If you had a choice of an easy patient and a not so
easy one, what would you go for? That’s the reality
and I’m sorry but that’s the basic truth.
(Pharmacist_Female_59yrs_Independent pharmacy).
Reflexive monitoring
Reflexive monitoring is the construct which concerns it-
self with assessment of the efficacy of the new practice
(appraisal work). This includes assessment of practice in
a formal, communal sense, but also undertaking an in-
formal individual appraisal. This ongoing assessment
and how work is modified in response to these
appraisals is important to maintaining ‘normalization’.
Participants were asked to appraise their work following
the learning. Overall, pharmacists recognised that
recruiting patients from medically under-served groups
was worthwhile. Despite the significant organisational
constraints, several pharmacists had adjusted their prac-
tice, the learning instilling confidence for them to step
out of their ‘comfort zone’ to adopt new procedures:
I had a patient who was Chinese and somehow
through some sort of signing or whatever I was able to
get my message across. Maybe I wouldn’t have tried
that MUR before, but I thought “no, I’m going to do
this” … Today a patient who I never realised had
ADHD got quite enraged in the pharmacy … Maybe
before I may have banned him … He got quite
aggressive over a refund … I said “let’s go and have
a chat, let’s go and have a bit of time out”. That
actually turned into an MUR, and it was as a
result of the e-learning because of me thinking
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“under-served”. (Pharmacist_Male_35yrs_Chain
pharmacy).
I would have been wary of doing an MUR with
somebody who’s deaf, and since then I’ve done 2
people who are deaf … I’ve got somebody else who’s
with them to come in and they helped with lip reading
… It takes a bit longer, but actually I can see this type
of group benefitting because nobody really takes the
time to speak to them.
(Pharmacist_Male_51yrs_Chain pharmacy).
Towards equity
To further appraise the impact of the learning interven-
tion, our final theme explores the views of patients from
medically under-served groups (who accepted an MUR
from the pharmacist and then were subsequently inter-
viewed). Most patients reported significant health issues
and medicines-related problems. Several described dis-
crimination; their social determinants of health acting as
barriers to receiving health care:
I was on heroin. People used to look at me and think
“No not helping him”. I have been shunned from a few
agencies. I’ve been shunned at hospital as well when
they find out your background … They’ve made me
feel it all, guilt. You’ve got yourself in that predicament
… For years I didn’t go to the doctors … if I wanted
medicine I could get it off the old boy down the street.
I didn’t go and see the doctor because I was crucified
for going in there. So, I ended up taking black market
medication. (Patient_Male_44yrs_substance misuse).
All patients agreed there was not enough health and
medicine support for those who were vulnerable and
medically under-served. There were several accounts of
inadequately managed medicines, poor adherence and
concerns over side-effects:
I get confused as I’ve had a stroke … Sometimes,
I know it sounds mad, I can’t be bothered because
they’re too many … I’m blind as a bat so when
reading them I’m not sure which ones I’m supposed
to take, when I supposed to take or how I’m
supposed to take it.
(Patient_Female_58yrs_disability_homebound).
When asked about their experience of the MUR,
the ad hoc offer came as a surprise who were expect-
ing just to collect their prescriptions. Being unfamiliar
with this service, some were puzzled and even ner-
vous as to why the pharmacist had asked to speak to
them:
Found it a bit strange … I thought you always had
that chat with the doctor and thought the pharmacist
was there to just sort out your medication.
(Patient_Female_52yrs_mental health illness).
I felt quite nervous because at that time I didn’t
realise why they were calling me in and I was
chosen randomly, it felt quiet obscure.
(Patient_22yr_ undertaking gender transition and
registered disabled).
During the consultation, all patients felt welcomed and
were pleased by the way they were treated. They found
the pharmacist to be kind and respectful:
She explained about the medicine, “are you OK now,
how are you feeling?” She was nice, very nice.
(Patient_Male_55yrs_Black community).
When asked to reflect on the purpose and value of
the MUR, patients framed this as an opportunity for
them to ask questions, learn and understand more
about their medicines and how to take them more ef-
fectively. They appreciated the opportunity to sit with
the pharmacist and have a chance to discuss their
medicines:
She told me I need to keep my blue inhaler with me at
all times as I sounded chesty and wheezy and I have
COPD. [Prior to that did you not keep your inhaler
with you?] No, but will do now.
(Patient_Male_44yrs_mental health illness).
She asked me if I wanted to ask any questions, but I
didn’t feel like I had to, she covered all bases. She told
me about my medications, told me when to take them,
what I was to do if I took too many, an overdose, and
things like that … I think it was to get me to
understand what medication I was on and what they
were for. (Patient_Female_39yrs_mental health
illness).
Although their MURs were able to resolve some prob-
lems, it was acknowledged that further help including
‘outreach services’ were urgently needed and that ‘gov-
ernment cut-backs’ to local services meant there were
fewer resources to meet patient needs.
Discussion
This study adds to the debate on how equitable improve-
ments to primary care services for vulnerable populations
can be promoted [49]. It explores the implementation of a
new co-produced digital educational intervention to im-
prove access, drawing in particular on NPT to understand
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how the intervention is enacted and embedded in practice.
It also considers the impact of how the intervention and
its implementation is experienced from the perspective of
patients from the target population. Regarding the learn-
ing, pharmacists and their support staff reported several
well documented barriers to learning. These were similar
to those reported when undertaking continuing profes-
sional development (CPD) including not having time, lack
of resources and interest [50]. Incorporating CPD as a
form of in situ workplace learning has been suggested to
improve engagement and professional practice [51]. How-
ever, our study suggests the perceived excessive workload
within pharmacies, creates a barrier to undertaking new
learning and constrains applying this knowledge in the
workplace [52].
The findings from the four constructs of NPT frame-
work revealed the complexity and extent to which the
outcomes from the learning became normalised in prac-
tice. Under the coherence theme, the findings revealed
there were improvements in awareness and better un-
derstanding of health inequities including how they oc-
curred. However, cognitive participation and collective
action remained limited due to organisational barriers
and work place constraints. This hindered effective prac-
tice change to occur and to be sustained. When apprais-
ing their work (reflexive monitoring), most success was
seen when pharmacists took it upon themselves to effect
change; when this occurred, there was real potential for
this to overcome the barriers to implementation and to
achieve and maintain normalization. It could be that
pharmacists who had been proactive, had positive atti-
tudes to innovation or were, ‘early adopters’ [53]. Others
have described these pharmacists as engaging fully with
training and learning activities, being receptive to in-
novative behaviours and welcoming greater autonomy
[54]. Nevertheless, effective ways to address inequity
should seek to involve staff from all levels with equal
motivation to participate in ‘readiness for change’ where
these could contribute to improving practice [55].
Regarding the impact on patients, MURs were wel-
comed and the extra help and support these afforded were
appreciated. In terms of Levesque et al. [56] model of con-
ceptualising access, the learning had promoted abilities to
perceive, seek, reach and engage with several medically
under-served groups. It is well reported that people from
these groups are more likely to manage health as a series
of minor and major crises, rather than treating diseases as
requiring maintenance and prevention [57]. Where the
intervention was successfully implemented and profes-
sional learning was successfully implemented, there was
potential for patient benefit. In times where questions are
being asked about whether MURs represent value for
money, targeting MURs to marginalised or medically
under-served groups could be a valuable step towards
demonstrating their relevance within certain medically
under-served groups. However, it is clear that further re-
search is needed to address the structural inequities within
the system.
Strengths and limitations
Whereas other studies using NPT have been criticised
for not moving beyond a single stakeholder perspective
[46], the present study used a range of stakeholders in-
cluding patient, pharmacist and pharmacy support staff.
These differing perspectives improved the credibility and
transferability of the findings. Furthermore, in order to
get a more balanced view, accounts were also taken from
those who had not completed the digital educational re-
source. It is however not known what extent the digital
learning accommodated for different learning prefer-
ences as this was beyond the scope of the present study.
Interventions can be applied at three levels: across the in-
dividual level that directly affect a patients’ social situation,
at a health care organisational level aimed at professionals,
and at a community or societal-level interventions, inclu-
ding social and political advocacy and research [58]. We
accept that the intervention focuses predominantly on
supply-side determinants to access, with less attention to
facilitating demand-side determinants. As O’Donnell [59]
notes, demand-side and supply-side barriers should be
addressed concurrently in order to tackle the problem of
access. Further research is needed to explore strategies on
how awareness of the benefits of an MUR can be better
promoted to patients from diverse backgrounds. In
addition, more investment is needed to develop novel
equity interventions [60] and evaluate their impact on
patient care.
Conclusions
Improving fairness, social justice and addressing inequit-
able access to health services features as a key priority
for the UK NHS [15]. However, health disparities are
still evident resulting in vulnerable patients experiencing
significant problems with their health and managing
medicines [41]. The co-produced digital educational
intervention described in this paper aimed to support
pharmacy teams to promote MURs to people medically
under-served. Despite the significant challenges to
implementing the learning, and normalising practice,
patients from medically under-served backgrounds who
were offered an MUR found this to be valuable and
worthwhile.
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